%0 Generic
%T Neo-/adjuvant phase III trial to compare intense dose-dense (idd) treatment with EnPC to tailored dose-dense (dt) therapy with dtEC-dtD for patients with high-risk early breast cancer: Results on pathological complete response (pCR) for patients treated within the neoadjuvant setting.
%A Moebus, Volker
%A Noeding, Stefanie
%A Ladda, Ekkehart
%A Klare, Peter
%A Schmidt, Marcus
%A Schneeweiss, Andreas
%A Janni, Wolfgang
%A Marmé, Frederik
%A Reimer, Toralf
%A Schmatloch, Sabine
%A Stickeler, Elmar
%A Untch, Michael
%A Sinn, Bruno Valentin
%A Müller, Volkmar
%A Fasching, Peter A.
%A Von Minckwitz, Gunter
%A Furlanetto, Jenny
%A Burchardi, Nicole
%A Loibl, Sibylle
%I American Society of Clinical Oncology (ASCO)
%@ 0732-183X
%@ 1527-7755
%K Cancer Research
%K Oncology
%D 2018
%C American Society of Clinical Oncology (ASCO)
%U http://slubdd.de/katalog?TN_libero_mab2
Download citation